REGENERON-PHARMACEUTICALS

REGENERON-PHARMACEUTICALS

Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been a significant player in the biotechnology industry, known for its innovative treatments and therapies. However, a recent trend among the company's insiders has raised eyebrows, with multiple executives and key personnel selling off large amounts of stock over the past year..

REGENERON-PHARMACEUTICALS

Livforsakringsbolaget Skandia Omsesidigt Buys 2,900 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Introduction In a strategic move aimed at bolstering its pharmaceutical portfolio, Livforsakringsbolaget Skandia Omsesidigt has significantly increased its stake in Regeneron Pharmaceuticals, Inc..